Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Persistent psychosis after treatment with interferon alpha: a case report.

Telio D, Sockalingam S, Stergiopoulos V.

J Clin Psychopharmacol. 2006 Aug;26(4):446-7. No abstract available.

PMID:
16855476
2.

[Protective effect of olanzapine in psychotic disorder induced by interferon-alpha].

D'Innella P, Zaccala G, Terazzi M, Olgiati P, Torre E.

Recenti Prog Med. 2003 Jul-Aug;94(7-8):343-4. Italian. No abstract available.

PMID:
12868244
3.

Treatment of interferon-induced psychosis in patients with comorbid hepatitis C and HIV.

Hoffman RG, Cohen MA, Alfonso CA, Weiss JJ, Jones S, Keller M, Condemarín JR, Chiu NM, Jacobson JM.

Psychosomatics. 2003 Sep-Oct;44(5):417-20. No abstract available.

PMID:
12954918
4.

Acute psychosis after injection of pegylated interferon alpha-2a.

Thome J, Knopf U.

Eur Psychiatry. 2003 May;18(3):142-3. No abstract available.

PMID:
12763304
5.

Prolonged psychosis associated with interferon therapy in a patient with hepatitis C: case study and literature review.

Cheng YC, Chen CC, Ho AS, Chiu NY.

Psychosomatics. 2009 Sep-Oct;50(5):538-42. doi: 10.1176/appi.psy.50.5.538.

PMID:
19855041
6.

Incidence of psychiatric side effects during pegylated interferon- alpha retreatment in nonresponder hepatitis C virus-infected patients.

Quarantini LC, Bressan RA, Galvão A, Batista-Neves S, Paraná R, Miranda-Scippa A.

Liver Int. 2007 Oct;27(8):1098-102.

PMID:
17845538
7.

Manic induction with interferon alpha therapy.

Goh T, Dhillon R, Bastiampillai T.

Aust N Z J Psychiatry. 2011 Nov;45(11):1004. doi: 10.3109/00048674.2011.615296. Epub 2011 Oct 7. No abstract available.

PMID:
21981775
8.

Chronic paranoid psychosis and dementia following interferon-alpha treatment of hepatitis C: a case report.

Drozdz W, Borkowska A, Wilkosc M, Halota W, Dybowska D, Rybakowski JK.

Pharmacopsychiatry. 2007 Jul;40(4):146-8.

PMID:
17694476
9.

Case of mania induced by withdrawal of interferon-alpha in a patient affected by bipolar disorder.

Rossi A, Renzetti D, D'Albenzio L, Gianfelice D, Kalyvoka A, Rinaldi O.

Psychiatry Clin Neurosci. 2002 Dec;56(6):647-8. No abstract available.

10.

[Ischemic anterior optic neuropathy complicating interferon alpha-2a and ribavirin treatment for acute hepatitis C].

Yaghi C, Baz P, Koussa S, Daniel F, Haddad F, Sayegh R.

Gastroenterol Clin Biol. 2005 May;29(5):616-7. French. No abstract available.

PMID:
15980766
11.

Psychosis associated with interferon alfa therapy for chronic hepatitis B.

Tamam L, Yerdelen D, Ozpoyraz N.

Ann Pharmacother. 2003 Mar;37(3):384-7.

PMID:
12639168
12.

Interferon for hepatitis C patients with psychiatric disorders.

Rifai MA, Bozorg B, Rosenstein DL.

Am J Psychiatry. 2004 Dec;161(12):2331-2; author reply 2332-4. No abstract available.

PMID:
15569919
13.

A patient with acute hepatitis C and possible IFN toxicity.

Licata A, Di Marco V, Craxì A.

Dig Liver Dis. 2003 May;35(5):372-3. No abstract available.

PMID:
12846412
14.

Rapid onset of hematotoxic effects after interferon alpha in hepatitis C.

Dormann H, Krebs S, Muth-Selbach U, Brune K, Schuppan D, Hahn EG, Schneider HT.

J Hepatol. 2000 Jun;32(6):1041-2. No abstract available.

PMID:
10898329
15.

Side effects. Bone problems may occur with hepatitis treatment.

[No authors listed]

TreatmentUpdate. 2000 Sep;12(6):7-8. No abstract available.

PMID:
12132465
16.

Interferon-induced obsessive-compulsive disorder.

DeRosse P, Szeszko PR, Malhotra AK.

Gen Hosp Psychiatry. 2006 Jul-Aug;28(4):357-8. No abstract available.

PMID:
16814637
17.

Severe interstitial pneumonitis secondary to pegylated interferon alpha-2b and ribavirin treatment of hepatitis C infection.

Fuhrmann V, Kramer L, Bauer E, Laferl H, Tucek G, Dekan G, Schenk P.

Dig Dis Sci. 2004 Nov-Dec;49(11-12):1966-70. No abstract available.

PMID:
15628735
18.

Major depressive episode with psychotic features induced by pegylated interferon-alpha-2b and ribavirin treatment.

Sockalingam S, Balderson K.

Int Clin Psychopharmacol. 2005 Sep;20(5):289-90.

PMID:
16096520
19.

[Myasthenia during interferon alpha therapy].

Quilichini R, Mazzerbo F, Baume D, Amiel O, Lafeuillade A, Pellegrino P.

Presse Med. 1995 Sep 2-9;24(25):1178. French. No abstract available.

PMID:
7567837
20.

[Severe ocular bacterial infection associated with pegylated interferon and ribavirin treatment for hepatitis C].

Khalil A, Gonzalez F, El Riachy E, Lucidarme D, Filoche B.

Gastroenterol Clin Biol. 2005 Nov;29(11):1187-8. French. No abstract available.

Supplemental Content

Support Center